Ocean Biomedical, Inc. Common Stock
OCEA
OCEA was delisted on the 23rd of April, 2025.
1 hedge funds and large institutions have $0 invested in Ocean Biomedical, Inc. Common Stock in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 6 closing their positions.
86% less funds holding
Funds holding: 7 → 1 (-6)
100% less capital invested
Capital invested by funds: $5.69K → $0 (-$5.69K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 6
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$3.07K |
| 2 |
Vanguard Personalized Indexing Management
Oakland,
California
|
-$2.27K |
| 3 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
-$278 |
| 4 |
SMA
Sage Mountain Advisors
Atlanta,
Georgia
|
-$76 |
OCEA Hedge Fund Activity: Q3 2025 in Review
1 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomedical, Inc. Common Stock (OCEA) for Q3 2025, worth a combined $0 — down 100% from $5.69K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of OCEA and 0 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was XTX Topco, exiting entirely with an estimated $3.07K sold.
- 1 institutional investor held Ocean Biomedical, Inc. Common Stock (OCEA) as of Q3 2025, down from 7 in Q2 2025.
- Funds reported $0 of Ocean Biomedical, Inc. Common Stock stock for Q3 2025, down 100% quarter-over-quarter.
- 0 funds opened new Ocean Biomedical, Inc. Common Stock positions in Q3 2025 and 6 closed out, a net change of -6 holders.
- The largest Ocean Biomedical, Inc. Common Stock seller in Q3 2025 was XTX Topco, an estimated $3.07K sold.
Based on aggregated 13F filings for Q3 2025.